LSE:MXCT (MaxCyte, Inc.)

About MXCT

A US-based developer and supplier of cell engineering technology to biotechnology and pharmaceutical firms engaged in cell therapy, drug discovery and development, biomanufacturing, gene editing and immuno-oncology.